D-(+)-Galactose D-galactose, a reducing sugar, is an aldohexose found in many foods, including dry figs, honey, and milk products
According to the SmPC and STEP clinical trials, these include: Nausea (affecting approximately 40-45% of patients) Vomiting (approximately 15-25% of patients) Diarrhoea (affecting approximately 25-30% of users) Constipation (approximately 20-25% of patients) Abdominal pain and bloating Gastro-oesophageal reflux For individuals taking oral anti-epileptic medications , severe or persistent vomiting could theoretically reduce drug absorption, potentially affecting seizure control
Medical conditions : Conditions such as hyperparathyroidism, recurrent urinary tract infections, inflammatory bowel disease, bariatric surgery (causing enteric hyperoxaluria), and certain genetic disorders predispose individuals to kidney stones
[37] According to a review, proton density fat fraction estimation by magnetic resonance imaging (MRI-PDFF) may be considered the most accurate and even gold standard test to quantify hepatic steatosis
The results of a two-year clinical trial, which will be available later this year, are expected to shed more light on the topic
Tirzepatide, the active ingredient, is a peptide molecule that can degrade over time through various chemical processes including oxidation, deamidation, and aggregation
